BSG and glioblastoma: Cluster of differentiation 147 (CD147) also termed basigin (BSG), or extracellular matrix metalloproteinase inducer, is a transmembrane glycoprotein with pleiotropic functions that is overexpressed in a broad range of malignant tumors and serves as a promising prognostic biomarker for glioblastoma, colorectal, oral, lung, prostate, and many other types of cancer [22].